Evidence map›Paper›PMID 32028623›Full record

ReviewBiomolecules2020

Therapeutic Potential of Plant Phenolic Acids in the Treatment of Cancer.

Mariam Abotaleb, Alena Liskova, Peter Kubatka, Dietrich Büsselberg

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 175 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
175citing papers in PubMed, 3 pooled it
18.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

175 citing papers in PubMed, 3 syntheses or guidelines pooled it, 398 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Ferulic andRSC advances · 2026
    Article
  13. Article
  14. Article
  15. Comparative Metabolomics and Transcriptomics Analysis ofMolecules (Basel, Switzerland) · 2026
    Article
  16. Antitumor-Directed Fractionation ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  17. Review
  18. Article
  19. Article
  20. Phytochemical Profiling and Anticancer Potential ofAnti-cancer agents in medicinal chemistry · 2026
    Article

115 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Mariam AbotalebDepartment of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha P.O. Box 24144, Qatar.
Alena LiskovaDepartment of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
Peter KubatkaDepartment of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
Dietrich BüsselbergDepartment of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha P.O. Box 24144, Qatar.
Comenius University Bratislava · SKWeill Cornell Medical College in Qatar · QA

Funding

Qatar National Research Fund NPRP 11S-1214-170101
6 · The paper itself

Abstract

Globally, cancer is the second leading cause of death. Different conventional approaches to treat cancer include chemotherapy or radiotherapy. However, these are usually associated with various deleterious effects and numerous disadvantages in clinical practice. In addition, there are increasing concerns about drug resistance. In the continuous search for safer and more effective treatments, plant-derived natural compounds are of major interest. Plant phenolics are secondary metabolites that have gained importance as potential anti-cancer compounds. Phenolics display a great prospective as cytotoxic anti-cancer agents promoting apoptosis, reducing proliferation, and targeting various aspects of cancer (angiogenesis, growth and differentiation, and metastasis). Phenolic acids are a subclass of plant phenolics, furtherly divided into benzoic and cinnamic acids, that are associated with potent anticancer abilities in various in vitro and in vivo studies. Moreover, the therapeutic activities of phenolic acids are reinforced by their role as epigenetic regulators as well as supporters of adverse events or resistance associated with conventional anticancer therapy. Encapsulation of phyto-substances into nanocarrier systems is a challenging aspect concerning the efficiency of natural substances used in cancer treatment. A summary of phenolic acids and their effectiveness as well as phenolic-associated advances in cancer treatment will be discussed in this review.

Indexed as

Angiogenesis InhibitorsAnimalsAntineoplastic Agents, PhytogenicApoptosisBenzoic AcidCell DifferentiationCinnamatesEpigenesis, GeneticGallic AcidHumansHydroxybenzoatesNeoplasm MetastasisNeoplasmsNeovascularization, PathologicPhytochemicalsPlantsAngiogenesis InhibitorsAntineoplastic Agents, PhytogenicBenzoic AcidCinnamatescinnamic acidGallic AcidHydroxybenzoatesphenolic acidPhytochemicalssyringic acidapoptosisbenzoic acidscancercinnamic acidsmetastasisphenolicsproliferation

Identifiers

PMID32028623
PMCPMC7072661
OpenAlexW3003385877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.